105 related articles for article (PubMed ID: 38787937)
1. Carcinogenic risk in patients treated with UVA-1 phototherapy: A 5-year retrospective study.
Cosetti D; Cioppa V; Rubegni P; Trovato E
Photodermatol Photoimmunol Photomed; 2024 May; 40(3):e12975. PubMed ID: 38787937
[TBL] [Abstract][Full Text] [Related]
2. Interventions for morphea.
Albuquerque JV; Andriolo BN; Vasconcellos MR; Civile VT; Lyddiatt A; Trevisani VF
Cochrane Database Syst Rev; 2019 Jul; 7(7):CD005027. PubMed ID: 31309547
[TBL] [Abstract][Full Text] [Related]
3. Incidence and profile of skin cancers in patients following ultraviolet phototherapy without psoralens: A retrospective cohort study.
Wang E; Ahad T; Liu YA; Lee TK; Lui H; Crawford RI; Kalia S
J Am Acad Dermatol; 2024 Apr; 90(4):759-766. PubMed ID: 38070541
[TBL] [Abstract][Full Text] [Related]
4. Long-term efficacy of medium-dose UVA1 phototherapy in atopic dermatitis.
Abeck D; Schmidt T; Fesq H; Strom K; Mempel M; Brockow K; Ring J
J Am Acad Dermatol; 2000 Feb; 42(2 Pt 1):254-7. PubMed ID: 10642681
[TBL] [Abstract][Full Text] [Related]
5. Phototherapy with UVB narrowband, UVA/UVBnb, and UVA1 differentially impacts serum 25-hydroxyvitamin-D3.
Feldmeyer L; Shojaati G; Spanaus KS; Navarini A; Theler B; Donghi D; Urosevic-Maiwald M; Glatz M; Imhof L; Barysch MJ; Dummer R; Roos M; French LE; Surber C; Hofbauer GF
J Am Acad Dermatol; 2013 Oct; 69(4):530-6. PubMed ID: 23850091
[TBL] [Abstract][Full Text] [Related]
6. [Phototherapy in severe atopic dermatitis. Comparison between current UVA1 therapy, UVA1 cold light and combined UVA-UVB therapy].
von Kobyletzki G; Freitag M; Herde M; Höxtermann S; Stücker M; Hoffmann K; Altmeyer P
Hautarzt; 1999 Jan; 50(1):27-33. PubMed ID: 10068928
[TBL] [Abstract][Full Text] [Related]
7. A cross-sectional analysis of skin cancer risk in patients receiving narrow-band ultraviolet B phototherapy: an evaluation of 100 patients.
Karaosmanoglu N; Ozdemir Cetinkaya P; Kutlu O; Karaaslan E; Imren IG; Kiratli Nalbant E; Eksioglu M
Arch Dermatol Res; 2020 May; 312(4):249-253. PubMed ID: 31729594
[TBL] [Abstract][Full Text] [Related]
8. Ultraviolet B phototherapy does not increase the risk of skin cancer among patients with atopic dermatitis: A population-based retrospective cohort study.
Ko MJ; Tsai WC; Tsai PH; Hsu LY; Chien KL; Wu HY
J Am Acad Dermatol; 2023 Sep; 89(3):496-503. PubMed ID: 37236426
[TBL] [Abstract][Full Text] [Related]
9. Medium-dose UVA1 cold-light phototherapy in the treatment of severe atopic dermatitis.
von Kobyletzki G; Pieck C; Hoffmann K; Freitag M; Altmeyer P
J Am Acad Dermatol; 1999 Dec; 41(6):931-7. PubMed ID: 10570376
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of ultraviolet A1 phototherapy for inflammatory, sclerotic and neoplastic dermatological diseases: A 10-year tertiary referral center experience.
Ronen S; Ramot Y; Zlotogorski A; Shreberk-Hassidim R
Photodermatol Photoimmunol Photomed; 2023 May; 39(3):256-262. PubMed ID: 36052749
[TBL] [Abstract][Full Text] [Related]
11. Incidence of skin cancers in 3867 patients treated with narrow-band ultraviolet B phototherapy.
Hearn RM; Kerr AC; Rahim KF; Ferguson J; Dawe RS
Br J Dermatol; 2008 Sep; 159(4):931-5. PubMed ID: 18834483
[TBL] [Abstract][Full Text] [Related]
12. Phototherapy of atopic dermatitis with ultraviolet radiation.
Jekler J
Acta Derm Venereol Suppl (Stockh); 1992; 171():1-37. PubMed ID: 1585754
[TBL] [Abstract][Full Text] [Related]
13. The effectiveness of high-dose ultraviolet A-1 phototherapy for acute exacerbation of atopic dermatitis in Asians.
Park JB; Jang JY; Kwon DI; Seong SH; Suh KS; Jang MS
Photodermatol Photoimmunol Photomed; 2020 Jul; 36(4):263-270. PubMed ID: 32141113
[TBL] [Abstract][Full Text] [Related]
14. Ultraviolet A phototherapy for sclerotic skin diseases: a systematic review.
Kroft EB; Berkhof NJ; van de Kerkhof PC; Gerritsen RM; de Jong EM
J Am Acad Dermatol; 2008 Dec; 59(6):1017-30. PubMed ID: 18835066
[TBL] [Abstract][Full Text] [Related]
15. The photocarcinogenic risk of narrowband UVB (TL-01) phototherapy: early follow-up data.
Man I; Crombie IK; Dawe RS; Ibbotson SH; Ferguson J
Br J Dermatol; 2005 Apr; 152(4):755-7. PubMed ID: 15840109
[TBL] [Abstract][Full Text] [Related]
16. UVA/UVB phototherapy for atopic dermatitis revisited.
Valkova S; Velkova A
J Dermatolog Treat; 2004 Jul; 15(4):239-44. PubMed ID: 15764039
[TBL] [Abstract][Full Text] [Related]
17. Photocarcinogenic Risk Associated With Narrowband UV-B Phototherapy: An Epidemiologic Study in a Tertiary Care Hospital.
Ortiz-Salvador JM; Ferrer DS; Saneleuterio-Temporal M; Victoria Martínez AM; Ferriols AP; Vilata Corell JJ; Alegre de Miquel V
Actas Dermosifiliogr (Engl Ed); 2018 May; 109(4):340-345. PubMed ID: 29463381
[TBL] [Abstract][Full Text] [Related]
18. UVA irradiation induced heme oxygenase-1: a novel phototherapy for morphea.
Nisar MF; Parsons KS; Bian CX; Zhong JL
Photochem Photobiol; 2015; 91(1):210-20. PubMed ID: 25207998
[TBL] [Abstract][Full Text] [Related]
19. Low-dose UVA₁ phototherapy for scleroderma: what benefit can we expect?
Pereira N; Santiago F; Oliveira H; Figueiredo A
J Eur Acad Dermatol Venereol; 2012 May; 26(5):619-26. PubMed ID: 21635565
[TBL] [Abstract][Full Text] [Related]
20. No evidence for increased skin cancer risk in Koreans with skin phototypes III-V treated with narrowband UVB phototherapy.
Jo SJ; Kwon HH; Choi MR; Youn JI
Acta Derm Venereol; 2011 Jan; 91(1):40-3. PubMed ID: 21031281
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
